Episurf Medical appoints Dr Michael Manley special advisor for US strategy
Episurf Medical (NASDAQ: EPIS B) today announced that it has appointed Dr Michael Manley as special advisor in support of its US strategy. Professor Leif Ryd, Senior Medical Advisor to Episurf Medical says: “Michael Manley has held leading positions in the orthopaedic industry within research and development for more than 30 years. He knows every detail in implant development." Dr Manley has been with Stryker Orthopaeidcs since 1987, was Chief Scientific Adviser until December 2016 and remains a consultant to the company in certain areas. After three decades, Dr Manley has extensive